InvestorsHub Logo
Followers 58
Posts 10180
Boards Moderated 1
Alias Born 09/21/2016

Re: abew4me post# 278269

Saturday, 10/24/2020 8:31:18 AM

Saturday, October 24, 2020 8:31:18 AM

Post# of 463933
abew

TGD knows what he's doing. History is about to be made.



Curious if anyone has assessed the AD vs PDD/PD trial criteria and test methods for similarities (equipment/intervals/metric/other)/ Is it possible some trial criteria are very much the same (cognitive test examples) where one might see clinical value in cross comparisons? (set AD= PDD)

We know Dr.M. and staff think outside the box. If the same fundamental dementia (BIOMED-Neuron)causes exist for loss in PDD as for loss in AD then possibly it is not such a leap to evaluate trial data in such a way. It is not exactly one size fits all but considering our MOA claims then this is a very rational possible learning opportunity.

This line of reasoning also makes the point that, "hey, it makes sense to review some PDD trial criteria-results". After all , if our MOA claims are valid it becomes a way to make a very powerful MOA point. IMO. Can you say BTD reasoning ???

So then, is a win in AD trial criteria similar to the same kind of win in PDD and visa versa?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News